Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

La Jolla, California

Phase 1 cancer trials in La Jolla, CA

37 Phase 1 cancer studies are recruiting participants at sites in La Jolla as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

La Jolla at a glance

Breast cancer studies recruiting in La Jolla

Basic details from each study's public record (the 30 most recently updated of 37). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    UCSD Moores Cancer Center
    Registry record
    NCT06253871 · updated
  2. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT06638307 · updated
  3. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla
    Registry record
    NCT03424005 · updated
  4. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT07029399 · updated
  5. A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    University of California, San Diego (UCSD) - Moores Cancer Center
    Registry record
    NCT06400472 · updated
  6. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    University of California, San Diego (UCSD) - Moores Cancer Center
    Registry record
    NCT06465069 · updated
  7. A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Mabwell (Shanghai) Bioscience Co., Ltd.
    Study site
    UCSD Moores Cancer Center
    Registry record
    NCT06908928 · updated
  8. A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genentech, Inc.
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT07100106 · updated
  9. Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Aminex Therapeutics, Inc.
    Study site
    University of California-San Diego
    Registry record
    NCT07287917 · updated
  10. A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Moores Cancer Center
    Registry record
    NCT06997029 · updated
  11. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    PMV Pharmaceuticals, Inc
    Study site
    University of San Diego Moores Cancer Center
    Registry record
    NCT04585750 · updated
  12. FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Fate Therapeutics
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT07216105 · updated
  13. FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Regor Pharmaceuticals Inc.
    Study site
    University of California, San Diego
    Registry record
    NCT05304962 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.

Lung cancer studies recruiting in La Jolla

  1. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT06287775 · updated
  2. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BlossomHill Therapeutics
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT06706076 · updated
  3. A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Frontier Medicines Corporation
    Study site
    University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center
    Registry record
    NCT06244771 · updated
  4. Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Scripps Clinic Torrey Pines (Scripps Cancer Center) · Scripps Green Hospital · Scripps Shiley Pavilion
    Registry record
    NCT07227298 · updated
  5. Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bicara Therapeutics
    Study site
    Moores Cancer Center UC San Diego Health
    Registry record
    NCT04429542 · updated
  6. A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ALX Oncology Inc.
    Study site
    ALX Center 9
    Registry record
    NCT07085091 · updated
  7. Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    University of California - San Diego Moores Cancer Center
    Registry record
    NCT06343402 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.

Prostate cancer studies recruiting in La Jolla

  1. First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT07332455 · updated
  2. A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Daiichi Sankyo
    Study site
    University of California San Diego Moores Cancer Center
    Registry record
    NCT07244341 · updated
  3. Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Acerand Therapeutics (Hong Kong) Limited
    Study site
    University of California San Diego, Moores Cancer Center
    Registry record
    NCT06801236 · updated
  4. Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janux Therapeutics
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT07545811 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.

Melanoma studies recruiting in La Jolla

  1. Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT05896839 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in La Jolla, CA on ClinicalTrials.gov.

Lymphoma studies recruiting in La Jolla

  1. Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT06860594 · updated
  2. A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    University of California San Diego Medical Center, Moores Cancer Center
    Registry record
    NCT07195916 · updated
  3. A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BeOne Medicines
    Study site
    University of California San Diego (Ucsd) Moores Cancer Center
    Registry record
    NCT05006716 · updated
  4. A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT06542250 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in La Jolla, CA on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in La Jolla

  1. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    UC San Diego Moores Cancer Center
    Registry record
    NCT06445062 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.

Ask about studies near La Jolla

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call